Found: 50
Select item for more details and to access through your institution.
Model-Predicted Impact of ECG Monitoring Strategies During Bedaquiline Treatment.
- Published in:
- Open Forum Infectious Diseases, 2022, v. 9, n. 8, p. 1, doi. 10.1093/ofid/ofac372
- By:
- Publication type:
- Article
Combined quantitative tuberculosis biomarker model for time-to-positivity and colony forming unit to support tuberculosis drug development.
- Published in:
- Frontiers in Pharmacology, 2023, v. 14, p. 1, doi. 10.3389/fphar.2023.1067295
- By:
- Publication type:
- Article
Editorial: Pharmacometrics--tools to assure optimal medicine use in low- and middle-income countries.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 01, doi. 10.3389/fphar.2022.1034807
- By:
- Publication type:
- Article
Machine Learning and Pharmacometrics for Prediction of Pharmacokinetic Data: Differences, Similarities and Challenges Illustrated with Rifampicin.
- Published in:
- Pharmaceutics, 2022, v. 14, n. 8, p. 1530, doi. 10.3390/pharmaceutics14081530
- By:
- Publication type:
- Article
Physiologically-Based Pharmacokinetic Modelling to Predict the Pharmacokinetics and Pharmacodynamics of Linezolid in Adults and Children with Tuberculous Meningitis.
- Published in:
- Antibiotics (2079-6382), 2023, v. 12, n. 4, p. 702, doi. 10.3390/antibiotics12040702
- By:
- Publication type:
- Article
The Population Pharmacokinetics of Meropenem in Adult Patients With Rifampicin-Sensitive Pulmonary Tuberculosis.
- Published in:
- Frontiers in Pharmacology, 2021, v. 12, p. 1, doi. 10.3389/fphar.2021.637618
- By:
- Publication type:
- Article
Early Bactericidal Activity of Meropenem plus Clavulanate (with or without Rifampin) for Tuberculosis: The COMRADE Randomized, Phase 2A Clinical Trial.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Constructing a representative in‐silico population for paediatric simulations: Application to HIV‐positive African children.
- Published in:
- British Journal of Clinical Pharmacology, 2021, v. 87, n. 7, p. 2847, doi. 10.1111/bcp.14694
- By:
- Publication type:
- Article
The pharmacokinetics of para‐aminosalicylic acid and its relationship to efficacy and intolerance.
- Published in:
- British Journal of Clinical Pharmacology, 2020, v. 86, n. 11, p. 2123, doi. 10.1111/bcp.14395
- By:
- Publication type:
- Article
Understanding the drug exposure–response relationship of bedaquiline to predict efficacy for novel dosing regimens in the treatment of multidrug‐resistant tuberculosis.
- Published in:
- British Journal of Clinical Pharmacology, 2020, v. 86, n. 5, p. 913, doi. 10.1111/bcp.14199
- By:
- Publication type:
- Article
Relative bioavailability of bedaquiline tablets suspended in water: Implications for dosing in children.
- Published in:
- British Journal of Clinical Pharmacology, 2018, v. 84, n. 10, p. 2384, doi. 10.1111/bcp.13696
- By:
- Publication type:
- Article
Normal fat mass cannot be reliably estimated in typical pharmacokinetic studies.
- Published in:
- European Journal of Clinical Pharmacology, 2021, v. 77, n. 5, p. 727, doi. 10.1007/s00228-020-03042-4
- By:
- Publication type:
- Article
Probability of mycobactericidal activity of para-aminosalicylic acid with novel dosing regimens.
- Published in:
- European Journal of Clinical Pharmacology, 2020, v. 76, n. 11, p. 1557, doi. 10.1007/s00228-020-02943-8
- By:
- Publication type:
- Article
Optimizing Dosing and Fixed-Dose Combinations of Rifampicin, Isoniazid, and Pyrazinamide in Pediatric Patients With Tuberculosis: A Prospective Population Pharmacokinetic Study.
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, n. 1, p. 141, doi. 10.1093/cid/ciab908
- By:
- Publication type:
- Article
High-Dose Oral and Intravenous Rifampicin for the Treatment of Tuberculous Meningitis in Predominantly Human Immunodeficiency Virus (HIV)-Positive Ugandan Adults: A Phase II Open-Label Randomized Controlled Trial.
- Published in:
- Clinical Infectious Diseases, 2021, v. 73, n. 5, p. 876, doi. 10.1093/cid/ciab162
- By:
- Publication type:
- Article
Rifampicin Can Be Given as Flat-Dosing Instead of Weight-Band Dosing.
- Published in:
- Clinical Infectious Diseases, 2020, v. 71, n. 12, p. 3055, doi. 10.1093/cid/ciz1202
- By:
- Publication type:
- Article
Model-Based Meta-analysis of Rifampicin Exposure and Mortality in Indonesian Tuberculous Meningitis Trials.
- Published in:
- Clinical Infectious Diseases, 2020, v. 71, n. 8, p. 1817, doi. 10.1093/cid/ciz1071
- By:
- Publication type:
- Article
The Potential for Treatment Shortening With Higher Rifampicin Doses: Relating Drug Exposure to Treatment Response in Patients With Pulmonary Tuberculosis.
- Published in:
- Clinical Infectious Diseases, 2018, v. 67, n. 1, p. 34, doi. 10.1093/cid/ciy026
- By:
- Publication type:
- Article
Assessing Prolongation of the Corrected QT Interval with Bedaquiline and Delamanid Coadministration to Predict the Cardiac Safety of Simplified Dosing Regimens.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 4, p. 873, doi. 10.1002/cpt.2685
- By:
- Publication type:
- Article
Power to identify exposure‐response relationships in phase IIa pulmonary tuberculosis trials with multi‐dimensional bacterial load modeling.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2024, v. 13, n. 3, p. 374, doi. 10.1002/psp4.13089
- By:
- Publication type:
- Article
Optimizing the design of a pharmacokinetic trial to evaluate the dosing scheme of a novel tuberculosis drug in children living with or without HIV.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2024, v. 13, n. 2, p. 270, doi. 10.1002/psp4.13077
- By:
- Publication type:
- Article
Exposure–safety analysis of QTc interval and transaminase levels following bedaquiline administration in patients with drug‐resistant tuberculosis.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2021, v. 10, n. 12, p. 1538, doi. 10.1002/psp4.12722
- By:
- Publication type:
- Article
Pharmacometrics meets statistics—A synergy for modern drug development.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2021, v. 10, n. 10, p. 1134, doi. 10.1002/psp4.12696
- By:
- Publication type:
- Article
A population pharmacokinetics analysis assessing the exposure of raltegravir once‐daily 1200 mg in pregnant women living with HIV.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2021, v. 10, n. 2, p. 161, doi. 10.1002/psp4.12586
- By:
- Publication type:
- Article
Characterizing Absorption Properties of Dispersible Pretomanid Tablets Using Population Pharmacokinetic Modelling.
- Published in:
- Clinical Pharmacokinetics, 2022, v. 61, n. 11, p. 1585, doi. 10.1007/s40262-022-01163-w
- By:
- Publication type:
- Article
Population Pharmacokinetics of Delamanid and its Main Metabolite DM-6705 in Drug-Resistant Tuberculosis Patients Receiving Delamanid Alone or Coadministered with Bedaquiline.
- Published in:
- Clinical Pharmacokinetics, 2022, v. 61, n. 8, p. 1177, doi. 10.1007/s40262-022-01133-2
- By:
- Publication type:
- Article
Population Pharmacokinetics and Bayesian Dose Adjustment to Advance TDM of Anti-TB Drugs.
- Published in:
- Clinical Pharmacokinetics, 2021, v. 60, n. 6, p. 685, doi. 10.1007/s40262-021-00997-0
- By:
- Publication type:
- Article
Correction to: A Model-Informed Method for the Purpose of Precision Dosing of Isoniazid in Pulmonary Tuberculosis.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
A Model-Informed Method for the Purpose of Precision Dosing of Isoniazid in Pulmonary Tuberculosis.
- Published in:
- Clinical Pharmacokinetics, 2021, v. 60, n. 7, p. 943, doi. 10.1007/s40262-020-00971-2
- By:
- Publication type:
- Article
Rethinking the Application of Pemetrexed for Patients with Renal Impairment: A Pharmacokinetic Analysis.
- Published in:
- Clinical Pharmacokinetics, 2021, v. 60, n. 5, p. 649, doi. 10.1007/s40262-020-00972-1
- By:
- Publication type:
- Article
Correction to: Evidence-Based Design of Fixed-Dose Combinations: Principles and Application to Pediatric Anti-Tuberculosis Therapy.
- Published in:
- 2020
- By:
- Publication type:
- corrected article
Clinical Pharmacokinetics and Pharmacodynamics of Rifampicin in Human Tuberculosis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Personalized Tuberculosis Treatment Through Model-Informed Dosing of Rifampicin.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Evidence-Based Design of Fixed-Dose Combinations: Principles and Application to Pediatric Anti-Tuberculosis Therapy.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Prediction of Moxifloxacin Concentrations in Tuberculosis Patient Populations by Physiologically Based Pharmacokinetic Modeling.
- Published in:
- Journal of Clinical Pharmacology, 2022, v. 62, n. 3, p. 385, doi. 10.1002/jcph.1972
- By:
- Publication type:
- Article
Model-based assessment of the safety of community interventions with primaquine in sub-Saharan Africa.
- Published in:
- Parasites & Vectors, 2021, v. 14, n. 1, p. 1, doi. 10.1186/s13071-021-05034-4
- By:
- Publication type:
- Article
Pharmacogenetics of Between-Individual Variability in Plasma Clearance of Bedaquiline and Clofazimine in South Africa.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Greater Early Bactericidal Activity at Higher Rifampicin Doses Revealed by Modeling and Clinical Trial Simulations.
- Published in:
- 2018
- By:
- Publication type:
- journal article
New and Repurposed Drugs for the Treatment of Active Tuberculosis: An Update for Clinicians.
- Published in:
- Respiration, 2023, v. 102, n. 2, p. 83, doi. 10.1159/000528274
- By:
- Publication type:
- Article
Investigating the treatment shortening potential of a combination of bedaquiline, delamanid and moxifloxacin with and without sutezolid, in a murine tuberculosis model with confirmed drug exposures.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2024, v. 79, n. 10, p. 2607, doi. 10.1093/jac/dkae266
- By:
- Publication type:
- Article
A pharmacometric multistate model for predicting long-term treatment outcomes of patients with pulmonary TB.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2024, v. 79, n. 10, p. 2561, doi. 10.1093/jac/dkae256
- By:
- Publication type:
- Article
Drug concentration at the site of disease in children with pulmonary tuberculosis.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Pharmacokinetics and safety of high-dose rifampicin in children with TB: the Opti-Rif trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Pharmacokinetics of antiretroviral and tuberculosis drugs in children with HIV/TB co-infection: a systematic review.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Clofazimine pharmacokinetics in patients with TB: dosing implications.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Is there a role for tedizolid in the treatment of non-tuberculous mycobacterial disease?
- Published in:
- 2020
- By:
- Publication type:
- journal article
Protein binding of rifampicin is not saturated when using high-dose rifampicin.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Modelling of mycobacterial load reveals bedaquiline's exposure-response relationship in patients with drug-resistant TB.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Population pharmacokinetic drug-drug interaction pooled analysis of existing data for rifabutin and HIV PIs.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Rifampicin and rifapentine significantly reduce concentrations of bedaquiline, a new anti-TB drug.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2015, v. 70, n. 4, p. 1106, doi. 10.1093/jac/dku504
- By:
- Publication type:
- Article